多肽定制服務(wù) | Peptides - MedChemExpress

多肽定制服務(wù)

多肽介紹

多肽是氨基酸以肽鍵連接在一起形成的化合物,具有多種生物學(xué)功能,例如抗血栓形成、抗高血壓、抗菌、抗病毒、抗癌、抗氧化、免疫調(diào)節(jié)、降膽固醇等,目前已廣泛用于功能分析、抗體研究、疫苗開(kāi)發(fā)及藥物研發(fā)等領(lǐng)域。

MCE 配備強(qiáng)大的技術(shù)人才團(tuán)隊(duì)和國(guó)際先進(jìn)的設(shè)備,提供全方位的高質(zhì)量定制肽服務(wù),包括快速肽合成、標(biāo)準(zhǔn)化學(xué)肽合成、肽修飾、肽庫(kù)和重組多肽表達(dá),以滿(mǎn)足生物與藥物發(fā)現(xiàn)研究中不斷增長(zhǎng)的多肽需求。

可選規(guī)格: 毫克(mg)級(jí)至公斤(kg)級(jí)。

純度范圍: 粗肽、脫鹽、70% 至 98%。

廣泛修飾: 可提供酰胺化、乙?;?、甲基化、磷酸化、標(biāo)記及偶聯(lián)等 300+ 種不同 修飾。

合成技術(shù): 結(jié)合固相合成及液相合成,微波和連接技術(shù)。

免費(fèi)咨詢(xún): 專(zhuān)業(yè)的 MCE 技術(shù)團(tuán)隊(duì)為您解答多肽定制的售前與售后的技術(shù)問(wèn)題。

多肽修飾

N 端修飾

?Ac

?Allyl

?Cholesteryl-

?N-Propargylglycine-

?Fmoc

?Acryl

?Fructose-

?Ad

?CBZ

?Alloc

?Glucose-

?BPS-

?Boc

?Pyr

?Morpholine-4-carbonyl-

?Bz

?D-Pyr

?NTriAc

?Trans-Cinnamoyl

?Bz (5-NH2,2-NO2)

?LA-

?PhAc

?2-Furoyl

?Bz (4-F)

?Mpa-

?Py-Ac

?Methacryl-

?Bz (4-NO2)

?Tos

?N-Amidinoglycine

?BPA-

C 端修飾

?-pNA

?-OMe

?-ONP

?-OSu

?-NH2

?-OEt

?-AMC

?-NHMe

?-ol

?-OBzl

?-AFC

?-NHEt

脂肪酸化

?For

?MeOSuc

?5-Hexynoic acid

?F-Lau-

?MeOCO

?Iba

?Heptanedioic acid

?Myr-

?2-Br-Ac

?pentenoic acid

?Oct-

?F-Myr-

?2-Cl-Ac

?pentinoyl

?F-Oct-

?Pentadeconyl-

?2-I-Ac

?Hex-

?Dec-

?Pal-

?OH-Ac

?5-heptenoic acid

?Sebacic acid

?Cys (Pal)

?3-Bromopropionyl

?Trans-3-hexenoyl-

?F-Dec-

?Pam3C-

?But-

?Linoletic-

?Undecyl-

?Ste-

?Suc

?10,12-Pentacosadiynoic acid

?Lau-

?Octanedioic acid

甲基化

?Lys (Me)

?Arg (Me)

?Tyr (Me)

?Tyr (Et)

?Lys (Me2)

?Arg (Me2)asymmetrical

?Thr (Me)

?D-Tyr (Et)

?Lys (Me3)

?Arg (Me2) symmetrical

?Ser (Me)

磷酸化

?pSer

?D-pSer

?Di-sites in sequence

?4-sites in sequence

?pTyr

?D-pTyr

?Tri-sites in sequence

?5-sites in sequence

?pThr

?D-pThr

支肽

?Symmetric 2 Branches

?Symmetric 4 Branches

?Symmetric 8 Branches

?Lys symmetric 2 Branches

?Lys symmetric 4 Branches

?Lys symmetric 8 Branches

?Orn symmetric 2 Branches

?Orn symmetric 4 Branches

?Orn symmetric 8 Branches

?Glu 2 Branches (Pure)

?Glycerol 3 Branches ester

?Thr (Peptide2)

?Ser (Peptide2)

?Lys (Peptide2)

環(huán)肽

?Mono Disulfide bridge

?Double Disulfide bridge

?Triple Disulfide bridge

?Random Triple Disulfide bridge

?Same Sequence Inter-Disulfide bridge by Cys oxidation

?Different Sequence Inter-Disulfide bridge by Cys oxidation

?Oxidation between Se-Cys

?Amide Cyclic (end)

?Amide Cyclic (side chain) by Lys

?Amide Cyclic (side chain) by Orn

熒光/染料標(biāo)記

?Biotin-

?FITC-

?Dansyl-

?Lys (Dnp)

?DeThioBiotin

?-ED-FITC

?-EDDansyl

?D-Lys (Dnp)

?-EDBiotin

?-Lys (FITC)-

?-Lys (Dansyl)-

?Dab (Dnp)

?Glu (Biotin-PEG2)

?-Lys (FITC)

?-Lys (Dansyl)

?Dap (Dnp)

?-Lys (Biotin)-

?Lys (Ahx-FITC)

?Dansli-e-Lys

?-EDDnp

?-Lys (Biotin)

?FITC-e-Lys

?Dansyl-Ahx-

?-Lys (LC-Biotin)-

?FITC-Ahx-

?5-FAM-

?-Lys (LC-Biotin)

?5-TAMRA-

?5,6-FAM

?Biotin-e-Lys

?5 (6)-TAMTA-

?6’FAM

?Lys (S-S-Biotin)

?-EDYAMRA

?-ED-5-FAM

?Biotin-Ahx-

?-Lys (TAMRA)-

?-Lys (5-FAM)-

?Orn (Bio)

?-Lys (5-TAMRA)

?Lys (5,6-FAM)

?MCA-

?5-TAMRA-e-Lys

?-Lys (5-FAM)

?-Lys (MCA)-

?5-TAMRA-Acp

?5-FAM-E-Lys

?-Lys (MCA)

?5-FAM-Ahx-

?Lys (MCA)-

BSA、KLH、OVA 偶聯(lián)

?BSA-Peptide N terminus

?KLH-Peptide N terminus

?OVA-Peptide N terminus

?BSA-Peptide C terminus

?KLH-Peptide C terminus

?OVA-Peptide C terminus

?BSA-Peptide via Cys

?KLH-Peptide via Cys

?OVA-Peptide via Cys

Phe & Tyr 衍生物

?D-2-Cl-Phe

?D-4-F-Phe

?L-2-Me-Phe

?L-3-I-Tyr

?L-2-Cl-Phe

?L-4-F-Phe

?D-4-Me-Phe

?D-3,5-DiI-Tyr

?D-3-Cl-Phe

?D-4-NO2-Phe

?L-4-Me-Phe

?L-3,5-DiI-Tyr

?L-3-Cl-Phe

?L-4-NO2-Phe

?D-4-NH2-Phe

?D-3-NO2-Tyr

?D-4-Cl-Phe

?D-4-I-Phe

?L-4-NH2-Phe

?L-3-NO2-Tyr

?L-4-Cl-Phe

?L-4-I-Phe

?D-3-Cl-Tyr

?D-3,5-DiNO2-Tyr

?D-3,4-DiCl-Phe

?D-3-CN-Phe

?L-3-Cl-Tyr

?L-3,5-DiNO2-Tyr

?L-3,4-DiCl-Phe

?L-3-CN-Phe

?D-3,5-DiCl-Tyr

?L-3-F-Tyr

?D-4-Br-Phe

?D-4-CN-Phe

?L-3,5-DiCl-Tyr

?L-4-NO2-Phg

?L-4-Br-Phe

?L-4-CN-Phe

?D-3,5-DiBr-Tyr

?D-4-NO2-Phg

?D-3-F-Phe

?D-2-Me-Phe

?L-3,5-DiBr-Tyr

?L-3,5-DiF-Phe

?L-3-F-Phe

?D-3-I-Tyr

Linker

?Gly

?Ava

?AEA

?GABA

?Beta-Ala

?Ahx

?Ado

?Mini-PEG

?Mini-PEG2

?Mini-PEG3

?PEG4

樹(shù)脂

?peptide on Wang Resin

?peptide on 2-CTC Resin

?peptide on Rink Amide AM Resin

?peptide on Rink Amide MBHA Resin

D 型氨基酸

?D-Ala

?D-Lys

?D-Glu

?D-Tyr

?D-Arg

?D-Met

?D-Gln

?D-Thr

?D-Asp

?D-Pro

?D-His

?D-Trp

?D-Asn

?D-Phe

?D-Leu

?D-Val

?D-Cys

?D-Ser

同型氨基酸

?Har

?HomoCit

?beta-HomoMet

?beta-HomoSer

?D-Har

?D-HomoCit

?beta-HomoPro

?beta-HomoThr

?Hcy

?HomoLeu

?beta-HomoVal

?beta-HomoTrp

?HPh

?HomoPro

?beta-HomoAsp

?beta-HomoTyr

?D-HPh

?D-HomoPro

?beta-HomoAsn

?Azidohomoalanine

?Hse

?beta-HomoIle

?beta-HomoGlu

?beta-HomoAla

?D-Hse

?beta-HomoLeu

?beta-HomoGln

?beta-HomoPhe

特殊氨基酸

?beta-Asp

?3-Thi

?D-Chg

?Cys (pMeBzl)

?D-beta-Asp

?Aib

?Ac6c

?Cys (pMeOBzl)

?gamma-Glu

?Abu

?Dab

?Oic

?D- gamma-Glu

?D-Abu

?Dap

?Tic

?Cys (Cam)

?Hyp

?Pra

?D-Tic

?D-Cys (Cam)

?Phg

?D-Pra

?Cys (Bzl)

?Cys (Acm)

?D-Phg

?Allo-Thr

?Epsilon-Lys

?Cys (tBu)

?Nva

?D-Allo-Thr

?D-Epsilon-Lys

?Cys (StBu)

?D-Nva

?Gly (allyl)

?5-ASA

?Met (O)

?Nle

?D-Gly (allyl)

?Bpa

?D-Met (O)

?D-Nle

?Cys (Pyrene-maleimide)

?Pip

?Cys (SNO)

?Cit

?D-1-Nal

?Nip

?Met (O)2

?D-Cit

?L-1-Nal

?2-Aze

?D-Met (O)2

?Orn

?D-2-Nal

?3-Aze

?Lys (Ac)

?D-Orn

?L-2-Nal

?[Psi (CH2NH)]

?Ac-Lys

?Pen

?D-2-Pal

?[CS-NH]

?Lys (Dde)

?D-Pen

?L-2-Pal

?Se-Met

?Tle

?Cpg

?D-3-Pal

?Se-Cys

?Ser (Octanoic acid)

?Cha

?L-3-pal

?DOPA

?Ser (Lipoic acid)

?D-Cha

?D-4-Pal

?isoGln

?D-Ser (Octanoic acid)

?Chg

?L-4-Pal

?D-isoGln

?Arg (Boc2)

?Asp-OMe

?D-Glu (OtBu)

?Lys (Z)

?Arg (NO2)

?Asp-OtBu

?Gln (Trt)

?Ser (Bzl)

?Arg (Z2)

?Asn (Trt)

?His (Boc)

?Ser (Trt)

?Arg (pbf)

?Cys (MMt)

?His (Trt)

?Ser (tBu)

?D-Arg (pdf)

?Cys (Trt)

?Tyr (propargyl)

?Tyr (tBu)

?Asp (Oall)

?D-Cys (Trt)

?Lys (Boc)

?Asp (OBn)

?Glu (Oall)

?Lys (DMT)

?D-Tyr (tBu)

?Asp (OBzl)

?Glu (OBzl)

?Lys (Fomc)

?Thr (tBu)

?Asp (OMe)

?Glu (OMe)

?Lys (Mtt)

?Trp (Boc)

?Asp (OtBu)

?Glu (OtBu)

?Lys (Trt)

?Trp (Farnesyl)

?著作權(quán)歸作者所有,轉(zhuǎn)載或內(nèi)容合作請(qǐng)聯(lián)系作者
【社區(qū)內(nèi)容提示】社區(qū)部分內(nèi)容疑似由AI輔助生成,瀏覽時(shí)請(qǐng)結(jié)合常識(shí)與多方信息審慎甄別。
平臺(tái)聲明:文章內(nèi)容(如有圖片或視頻亦包括在內(nèi))由作者上傳并發(fā)布,文章內(nèi)容僅代表作者本人觀點(diǎn),簡(jiǎn)書(shū)系信息發(fā)布平臺(tái),僅提供信息存儲(chǔ)服務(wù)。

相關(guān)閱讀更多精彩內(nèi)容

友情鏈接更多精彩內(nèi)容